Prof. Dr. med. Heiko Graf

Original- und Übersichtsarbeiten, Editorials, Fallberichte und sonstige Veröffentlichungen in chronologischer Reihenfolge (Stand Mai 2022)

Spitzer M, Graf H: Lithium im Trinkwasser – Lithium ins Trinkwasser ? Nervenheilkunde 29:157–158 (2010)

Graf H, Brummer D, Spiegel A, Abler B: Das Noonan-Syndrom – ein psychiatrischer Kolibri ? Nervenheilkunde 30(8):563-568 (2011)

Spitzer M, Graf H: Das Gehirn beim Nichtstun. Nervenheilkunde 30(12): 1005–1007 (2011)

Graf H, Abler B, Freudenmann R, Beschoner P, Schaeffeler E, Spitzer M, Schwab M, Grön G: Neural correlates of error monitoring modulated by atomoxetine in healthy volunteers. Biological Psychiatry 69(9):890-897 (2011) 

Graf H, Abler B, Hartmann A, Metzger CD, Walter M: Modulation of attention network activation under paroxetine and bupropion in healthy subjects. The International Journal of Neuropsychopharmacology 16(6):1219–1230 (2013)

Viviani R, Graf H, Wiegers M, Abler B: Effects of amisulpride on human resting cerebral perfusion. Psychopharmacology 229(1):95-103 (2013)

Metzger CD, Walter M, Graf H, Abler B: SSRI-related Modulation of Sexual Functioning is Predicted by Pre-treatment Resting State Functional Connectivity in Healthy Men. Archives of Sexual Behavior 42(6):935-947 (2013)

Graf H, Franke B, Abler B: Cerebellar Cognitive Affective Syndrome in Dandy-Walker variant disorder. The Journal of Neuropsychiatry and Clinical Neurosciences 25(3):E45-46 (2013)

Graf H, Gorges M, Kassubek J: Hypertrophe Degeneration des Nucleus olivaris: Klinisches Bild. Nervenheilkunde 32(8):532-537 (2013)

Graf H, Walter M, Metzger CD, Abler B: Antidepressant-related sexual dysfunction – perspectives from neuroimaging. Pharmacology Biochemistry & Behavior 121:138-145 (2014)

Graf H, Brummer D, Abler B: Noonan-syndrome – a considerably prevalent but neglected psychiatric differential diagnosis. The Journal of Neuropsychiatry and Clinical Neurosciences 26(3):E30 (2014)

Gahr M, Schönfeldt-Lecuona C, Spitzer M, Graf H: Electroconvulsive therapy (ECT) and post-traumatic stress disorder: first experience with conversation based reactivation of traumatic memory contents subsequent to ECT-related impairment of reconsolidation. The Journal of Neuropsychiatry and Clinical Neurosciences 26(3):E39-39 (2014)

Graf H, Abler B, Weydt P, Kammer T, Plener PL: Development, Implementation, and Evaluation of a Movie-Based Curriculum to Teach Psychopathology. Teaching and Learning in Medicine: An International Journal 26(1):86-89 (2014)

Graf H, Wiegers M, Metzger CD, Walter M, Grön G, Abler B: Erotic stimulus processing under amisulpride and reboxetine: a placebo controlled fMRI-study in healthy subjects. The International Journal of Neuropsychopharmacology Oct 31; 18(2) (2014)

Wurster CD*, Graf H*, Ackermann H, Groth K, Kassubek J, Riecker A: Neural correlates of rate-dependent finger-tapping in Parkinson`s disease. Brain Structure and Functions 220(3):1637-1648 (2015)  * contributed equally 

Metzger CD, Wiegers M, Walter M, Abler B, Graf H: Local and global resting-state activity in the noradrenergic and dopaminergic pathway modulated by reboxetine and amisulpride in healthy subjects. The International Journal of Neuropsychopharmacology 19:1-9 (2015) 

Graf H, Metzger CD, Walter M, Abler B: Serotonergic antidepressants decrease hedonic signals but leave learning signals in the nucleus accumbens unaffected. Neuroreport 27(1):18-22 (2016)

Malejko K, Graf H, Gahr M: Survival of Very High Blood Alcohol Concentration Without Consequential Damage in a Patient Without a Previous Substance Use Disorder. Journal of Forensic Sciences 61(4): 1155-1157 (2016) 

Malejko K, Abler B, Graf H: Neuronale Korrelate sexueller Funktionen unter Antidepressiva. Nervenheilkunde 35: 575–581 (2016) 

Graf H, Wiegers M, Metzger CD, Walter M, Grön G, Abler B: Noradrenergic modulation of neural erotic stimulus perception. European Neuropsychopharmacology 27(9):845-853 (2017) 

Graf H, Malejko K, Sosic-Vasic Z, Gahr M: Pharmakologisches kognitives Neuroenhancement und Neurotransmittersysteme. Nervenheilkunde 36(9):695-701 (2017)

Meier T, Ileva S, Ruf W, Freudenmann RW, Graf H: Dementiell-depressives Syndrom bei Chorea Huntington. Nervenheilkunde 36(9):735-738 (2017)

Schaitz C, Kröner J, Graf H, Sosic-Vasic Z: Zum Einsatz und Nutzen mentaler Bilder oder Imaginationen in der kognitiven Verhaltenstherapie. Nervenheilkunde 36(9): 719-725 (2017)

Malejko K, Abler B, Plener PL, Graf H, Straub J: Neuronale Korrelate psychotherapeutischer Behandlung bei Patienten mit posttraumatischer Belastungsstörung. Nervenheilkunde 36(9): 726-734 (2017)

Graf H, Wiegers M, Metzger CD, Walter M, Abler B: Differential noradrenergic modulation of monetary reward and visual erotic stimulus processing. Frontiers in Psychiatry 9:346 (2018)

Kocar T, Freudenmann RW, Spitzer M, Graf H: Switching from tobacco smoking to e-cigarettes and the impact on clozapine levels. Journal of Clinical Psychopharmacology 38(5): 1-2 (2018)

Graf H, Wurster CD: Antisense Oligonucleotides in Psychiatric Disorders. Journal of Clinical Psychopharmacology 38(6):1-2 (2018)

Malejko K, Neff D, Brown RC, Plener PL, Bonenberger M, Abler B, Grön G, Graf H: Somatosensory Stimulus Intensity Encoding in Borderline Personality Disorder. Frontiers in Psychology 9(1853): 1-9 (2018)

Malejko K, Abler B, Brown RC, Graf H: Neuronale Korrelate von sozialem Ausschluss bei psychischen Erkrankungen. Nervenheilkunde 37: 779-785 (2018) 

Rau V, Malejko K, Graf H: Belohnung und das Opioidsystem. Nervenheilkunde 37: 786-791 (2018)

Wurster CD, Ludolph AC, Lehmann D, Graf H: Antisense-Oligonukleotide I: Chemische Modifikationen, Wirkmechanismen und therapeutischer Einsatz bei neurodegenerativen Erkrankungen Nervenheilkunde 37: 809-817 (2018) 

Graf H, Lehmann D, Ludolph AC, Wurster CD: Antisense-Oligonukleotide II: Therapeutisches Potential bei neuropsychiatrischen Erkrankungen sowie ethische und gesundheitspolitische Aspekte. Nervenheilkunde 37: 818-823 (2018)

Malejko K, Neff D, Brown RC, Plener PL, Bonenberger M, Abler B, Graf H: Neural Correlates of Social Inclusion in Borderline Personality Disorder. Frontiers in Psychiatry 9(653): 1-11 (2018)

Graf H, Malejko K, Metzger CD, Walter M, Grön G, Abler B: Serotonergic, Dopaminergic and Noradrenergic Modulation of Erotic Stimulus Processing in the Human Brain. Journal of Clinical Medicine 8: 1-14 (2019)

Malejko K, Neff D, Brown RC, Plener PL, Bonenberger M, Abler B, Graf H: Neural signatures of social inclusion in borderline personality disorder versus non-suicidal self-injury. Brain Topography 32:753-761 (2019)

Malejko K, Brown RC, Plener PL, Bonenberger M, Graf H, Abler B. Differential neural processing of unpleasant sensory stimulation in patients with major depression. Eur Arch Psychiatry Clin Neurosci (2020)

Zeiss R, Schönfeldt-Lecuona C, Gahr M, Graf H: Depressive disorder with panic attacks after replacement of an intrauterine device containing levonorgestrel: a case report. Frontiers in Psychiatry 11: 1-5 (2020)

Zeiss R, Graf H, Gahr M, Schönfeldt-Lecuona C: Angst und Panik unter Hormonspirale. Deutsches Ärzteblatt 40: A1858-1861 (2020)

Malejko K, Huss A, Schönfeldt-Lecuona C, Braun M, Graf H: Emotional Components of Pain Perception in Borderline Personality Disorder and Major Depression – a repetitive peripheral magnetic stimulation (rPMS) study. Brain Sciences 20(905): 1-9 (2020)

Rüger A, Graf H: Lithium im Trinkwasser – Lithium ins Trinkwasser: 10 Jahre danach. Nervenheilkunde 40:48-52 (2021)

Malejko K, Abler B, Graf H: Neuronale Korrelate unangenehmer somatosensorischer Stimulation bei Patienten mit Borderline Persönlichkeitsstörung und Depression. Nervenheilkunde 40:53-59 (2021)

Malejko K, Hafner S, Brown RC, Plener PL, Bonenberger M, Abler B, Graf H: Neural signature of error processing in major depression. European Archives of Psychiatry and Clinical Neuroscience (2021)

Mix L, Winter B, Wurster CD, Platen S, Witzel S, Uzelac Z, Graf H, Ludolph AC, Lulé D: Quality of Life in SMA Patients Under Treatment With Nusinersen. Frontiers in Neurology 12:626787 (2021)

Zeiss R, Gahr M, Graf H: Rediscovering psilocybin as an antidepressant treatment strategy. Pharmaceuticals 14:985 (2021)

Steinacker P, Al Shweiki R, Oeckl P, Graf H, Ludolph AC, Schönfeldt-Lecuona C, Otto M: Glial fibrillary acidic protein as blood biomarker for differential diagnosis and severity of major depressive disorder. Journal of Psychiatric Research 144:54-58 (2021)

Healy D, Bahrick A, Bak M, Barbato A, Calabrò RS, Chubak BM, Cosci F, Csoka AB, D’Avanzo B, Diviccaro S, Giatti S, Goldstein I, Graf H, Hellstrom WJG, Irwig MS, Jannini EA, Janssen PKC, Khera M, Kumar MT, Le Noury J, Lew-Starowicz M, Linden DEJ, Lüning C, Mangin D, Melcangi RC, Rodriguez OW, Panicker JN, Patacchini A, Pearlman AM, Pukall CF, Raj S, Reisman Y, Rubin RS, Schreiber R, Shipko S, Vašečková B, Waraich A: Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin. International Journal of Risk & Safety in Medicine, in press, vol. Pre-press, no. Pre-Press, pp. 1-12 (2021) 

Kugelmann M, Graf H, Rüger A, Schönfeldt-Lecuona: Die schizoaffektive Störung – Eine diagnostische Entität mit vielen Gesichtern. Nervenheilkunde 41: 36-41 (2022)